HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. Alanazi SM, Feroz W, Mishra R, Kilroy MK, et al. PLoS One 2023;18:e0285251.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alanazi SM, Feroz W, Mishra R, Kilroy MK, et al. HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. PLoS One 2023;18:e0285251.
PMID: 37200287